<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Telomere shortening has been observed in many human diseases, including <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, aging syndromes, <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The present study aimed to investigate the mean telomere lengths of patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We analyzed the lengths of telomeric DNA, comparing 2 groups of patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> (34 good responders and 34 poor responders) </plain></SENT>
<SENT sid="3" pm="."><plain>A control group of 76 healthy volunteers was also included </plain></SENT>
<SENT sid="4" pm="."><plain>Blood samples were obtained, and telomere length was measured by Southern blot analysis on the mean length of terminal restriction fragment (TRF) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Compared with the control group, a significant amount of telomere shortening was found in peripheral blood leukocytes from patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> who experienced poor response to <z:chebi fb="0" ids="35476">antipsychotics</z:chebi> (p &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Shortened telomere length in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> may be a trait marker caused by <z:mp ids='MP_0003674'>oxidative stress</z:mp>, and the ensuing cellular dysfunction may be a factor contributing to the progressive deterioration in treatment-resistant <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> </plain></SENT>
</text></document>